PD-L1 monoclonal antibody

February 2019—Leica Biosystems launched a programmed death-ligand 1 antibody. The PD-L1 1 (73-10) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of endogenous PD-L1 protein in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the company’s fully automated Bond system. It joins the recently released ALK antibody as the latest addition to the company’s Novocastra menu of primary antibodies.

Pages: 1 2